Category: Blog

understanding ethnicity in lung cancer: are we there yet?

Lung cancer remains the leading cause of cancer mortality globally. Thanks to tobacco control efforts by the World Health Organization and others, great strides have been made in reducing overall prevalence. In spite of this, mortality rates continue to widen between non-Caucasians and Caucasians around the world. Evidence

INNOVARA DIGEST – OUR FAVORITE BIOTECH AND PHARMA NEWS BLOGS

With all of the biotech and pharma news blogs scattered throughout the internet, how do you stay informed without being overwhelmed? Narrowing your feed down to the most important information and insights is crucial. In this week’s Innovara Digest, we are covering our must-read picks.

NIH RESEARCH GRANT APPLICATIONS : A HANDY GUIDE FOR APPLICANTS AND REVIEWERS

If you have ever tried to figure out the US National Institutes of Health (NIH) process to review applications for approval and funding, you will find yourself bouncing between multiple landing pages and attachments. We have prepared the following guide to make NIH research grant applications easier for

4TH ANNUAL FMSL OPEN SEMINAR IN SEOUL

Thank you to all who helped make the 4th annual Foundations for Medical Science Liaisons™ (FMSL) open seminar, held July 24-26 in Seoul, Korea, a great success! The FMSL open seminar is an experiential learning course for Medical Science Liaisons, focused on functional competencies, communications, and value-added skills

INNOVARA DIGEST: 4 PCCQ™ STRATEGIES TO TRANSFORM YOUR HEALTH CARE ORGANIZATION

In January, our CEO, Barri Blauvelt, wrote a detailed piece on how Patient-centered Cultural Intelligence (PCCQ) can impact hospital performance. In this week’s Innovara Digest, we offer 4 simple PCCQ™ strategies for your health care organization that you can implement today, before you commit to becoming a PCCQ

social media in healthcare

On a rainy Friday, we took Barri Blauvelt, CEO out on the porch at Innovara to discuss social media in healthcare. Here’s what she had to say:

THE ERA OF GENETICALLY-TARGETING THERAPIES AND DIAGNOSTIC CHALLENGES: WHAT HAVE WE LEARNED?

When the FDA approved Keytruda for use in any tumor with the biomarker, I decided to investigate how a doctor and patient would diagnose the patient as a candidate for this treatment. This investigation, Diagnostic Challenges in the Era of Genetically-Targeting Master Brands, was published in Pharmaceutical Executive

THE ROADMAP TO HIGH PERFORMING MARKETERS

According to a newly-released study from Best Practices LLC, Innovara is the top company cited by global and US healthcare companies as best practice for both marketing training/curricula development and for consultancy/for-profit marketing training services. This is great news indeed. It validates our core approach to training and

we made changes to our open seminar schedule

Due to popular demand, we have added more courses to our open seminar schedule for 2017: We will hold our most popular marketing courses, Marketing Plan in Action (MPIA) and Advanced Strategic Marketing (ASM) in Jordan at the end of September. We are following them up with our

THE ROLE OF THE MSL TO IMPACT PATIENT VALUE: DO MSLS KNOW HOW?

Is it possible for MSLs to impact patient value while remaining compliant? Should this be a priority for your organization? Since January 2017, Innovara has been assessing hundreds of MSLs around the globe, for free. We are comparing their level of experience, what they value on-the-job, and their